Please see the mini-review below that proposes a package of precision medicine-guided therapies that has the prospect to drive clinical management decisions, based on both host immunity and M. tuberculosis strains genetics.
Related topics
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| Advances in Molecular Diagnosis of Tuberculosis | 0 | 743 | September 22, 2020 | |
| Target product profile for tuberculosis diagnosis and detection of drug resistance | 0 | 12 | August 14, 2024 | |
| A systematic comparison of 16 gene signatures for TB diagnosis | 0 | 585 | May 6, 2019 | |
| Tackling drug-resistant tuberculosis: we need a critical synergy of product and process innovations | 0 | 341 | August 23, 2019 | |
| Achieving universal access to rapid tuberculosis diagnostics | 0 | 330 | May 26, 2023 |